BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 23748228)

  • 1. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
    Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
    J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
    Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
    Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
    Caravan P
    Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-soluble gadofullerenes: toward high-relaxivity, pH-responsive MRI contrast agents.
    Tóth E; Bolskar RD; Borel A; González G; Helm L; Merbach AE; Sitharaman B; Wilson LJ
    J Am Chem Soc; 2005 Jan; 127(2):799-805. PubMed ID: 15643906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.
    Bolskar RD; Benedetto AF; Husebo LO; Price RE; Jackson EF; Wallace S; Wilson LJ; Alford JM
    J Am Chem Soc; 2003 May; 125(18):5471-8. PubMed ID: 12720461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
    Zhu D; Lu X; Hardy PA; Leggas M; Jay M
    Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure.
    Fretellier N; Bouzian N; Parmentier N; Bruneval P; Jestin G; Factor C; Mandet C; Daubiné F; Massicot F; Laprévote O; Hollenbeck C; Port M; Idée JM; Corot C
    Toxicol Sci; 2013 Jan; 131(1):259-70. PubMed ID: 22977165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
    Shu CY; Zhang EY; Xiang JF; Zhu CF; Wang CR; Pei XL; Han HB
    J Phys Chem B; 2006 Aug; 110(31):15597-601. PubMed ID: 16884284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
    Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG
    Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
    Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
    Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
    Zong Y; Guo J; Ke T; Mohs AM; Parker DL; Lu ZR
    J Control Release; 2006 May; 112(3):350-6. PubMed ID: 16631270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
    Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
    J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.
    Zhang J; Fatouros PP; Shu C; Reid J; Owens LS; Cai T; Gibson HW; Long GL; Corwin FD; Chen ZJ; Dorn HC
    Bioconjug Chem; 2010 Apr; 21(4):610-5. PubMed ID: 20218678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MS-325: albumin-targeted contrast agent for MR angiography.
    Lauffer RB; Parmelee DJ; Dunham SU; Ouellet HS; Dolan RP; Witte S; McMurry TJ; Walovitch RC
    Radiology; 1998 May; 207(2):529-38. PubMed ID: 9577506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images.
    Park JY; Baek MJ; Choi ES; Woo S; Kim JH; Kim TJ; Jung JC; Chae KS; Chang Y; Lee GH
    ACS Nano; 2009 Nov; 3(11):3663-9. PubMed ID: 19835389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.